Brief: Arno Therapeutics announces update to prostate cancer program
04/01/2017 21:20
Jan 5 (Reuters) - Arno Therapeutics Inc ARNI.PK
* Arno therapeutics announces update to onapristone prostate
cancer development program
Source text for Eikon: ID:nBw1Tvhrba
Further company coverage: ARNI.PK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Arno Therapeutics
See all newsBrief: Arno Therapeutics Announces Plans To Dissolve
Brief: Arno Therapeutics announces update to prostate cancer program
Brief: Arno Therapeutics reports Q1 adj loss of $0.05 per share
Brief: Arno Therapeutics reports Q3 loss per share $0.03
Brief: Arno Therapeutics Q1 adjusted non-GAAP loss per share $0.14